Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX)
Baron Funds, an investment management firm, released its “Focused Growth Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
Idexx Laboratories Inc (IDXX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Leucadia National Ian Cumming And Joseph Steinberg | 19,539 | $8,205,403 | -27% | 0.07% |
| 2. | Impax Asset Management Ian Simm | 8,853 | $3,717,817 | +4% | 0.02% |
| 3. | Tikehau Investment Management Mathieu Chabran And Antoine Flamarion | 4,544 | $1,908,253 | -3% | 2.95% |
| 4. | Bayforest Capital Theodoros Tsagaris | 496 | $107,087 | +78% | 0.09% |
| 5. | Hurley Capital Charles Goldblum | 22 | $9,239 | -69% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $266.41 | 375 | Director | 7,778 | 2019-08-06 | Filing | |
| $208.68 | 2,405 | Director | 7,403 | 2019-02-05 | Filing | |
| $242.12 | 415 | Director | 1,415 | 2018-08-03 | Filing | |
| $178.05 | 1,000 | Director | 4,558 | 2018-02-14 | Filing | |
| $179.58 | 1,000 | Director | 1,000 | 2018-02-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $462.53 | 9,986 | Officer | 8,176 | 2025-02-10 | Filing | |
| $465.95 | 3,000 | Director | 3,061 | 2025-02-07 | Filing | |
| $420.44 | 344 | Director | 905 | 2024-11-27 | Filing | |
| $469.37 | 500 | Director | 0 | 2024-09-06 | Filing | |
| $540.80 | 200 | Director | 161 | 2024-05-17 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,703,074 | $3,654,855,687 | 0.08% | |
| 2. | 1,126,002 | $472,864,953 | 0.27% | |
| 3. | 566,582 | $237,935,996 | 0.05% | |
| 4. | 551,764 | $231,713,292 | 1% | |
| 5. | 456,621 | $191,757,990 | 0.7% |
News See All
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q1 2025 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories' First Quarter 2025 Earnings Conference Call. As a reminder, today's conference is being recorded.
Should You Sell IDEXX Laboratories (IDXX)?
TimesSquare Capital Management, an equity investment management company, released its “U.S. Focus Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.
8 Best Pet Stocks to Buy According to Billionaires
The pet industry is expected to continue growing in the coming years, driven by changing consumer preferences and innovative trends.
12 Best Diagnostics Stocks to Invest In Right Now
According to a report by Mordor Intelligence, the clinical diagnostics market has a size of $88.79 billion as of 2025.
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory
We came across a bullish thesis on IDEXX Laboratories, Inc. (IDXX) on Substack by Hidden Market Gems. In this article, we will summarize the bulls’ thesis on IDXX. IDEXX Laboratories, Inc.
IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients
Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Here’s Why IDEXX Laboratories (IDXX) Declined in Q4
Conestoga Capital Advisors, an asset management company, released its fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here. For the second consecutive year, U.S.
Jim Cramer On 9 Stocks That Are Rallying Despite Tariff Worries
On Monday, Jim Cramer, the host of Mad Money, told viewers that they should not be too surprised by President Donald Trump's decision to impose steep tariff hikes, a move Trump had promised during his...
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q4 2024 Earnings Call Transcript
Operator: Good morning, and welcome to the IDEXX Laboratories' Fourth Quarter 2024 Earnings Conference Call. As a reminder, today's conference is being recorded.
Billionaire Hedge Funds
